Key facts
- The Global Fund will deploy a new molecular diagnostic test for TB.
- The test will be used in 13 countries.
- Nearly 3 million rapid tests will be provided.
- The total value of the tests is $13 million.
- The technology is supplied by Chinese firm Pluslife Biotech.
- The initiative aims to speed up TB diagnosis.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is set to deploy a new molecular diagnostic test for tuberculosis across 13 countries. This initiative aims to significantly speed up the diagnosis of TB. The program will provide approximately 3 million rapid tests, with a total value of $13 million. The technology powering these rapid tests is supplied by the Chinese firm Pluslife Biotech. This deployment is expected to enhance the speed of TB detection and facilitate quicker initiation of treatment for affected individuals in the participating nations.